Article

Send this article by email

Artigo Original

Should intravitreal dexamethasone implant in refractory diabetic macular edema be used as an adjuvant therapy or switch therapy?

Submission is temporarily unavailable. reCAPTCHA validation has not been configured yet.

How to cite this article:

Çakmak S, Demir G, Tunç U, Sukun EY, Akbas YB, Ozkaya A, et al. Should intravitreal dexamethasone implant in refractory diabetic macular edema be used as an adjuvant therapy or switch therapy?. Arq. Bras. Oftalmol. 2025;88(2): e2023-0229:1-6. 10.5935/0004-2749.2023-0229

Export citation